NYSEMKT: AEONAeon Biopharma Inc Stock Ownership - Who owns Aeon Biopharma?
Insider buying vs selling
Have Aeon Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when AEON insiders and whales buy or sell their stock.
AEON Shareholders
What type of owners hold Aeon Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Priveterra Sponsor LLC | 131.87% | 13,889,163 | $5.83M | Insider |
| Daewoong Co Ltd | 62.45% | 6,577,604 | $2.76M | Insider |
| Blue Owl Capital Holdings LP | 28.95% | 3,049,361 | $1.28M | Institution |
| Polar Asset Management Partners Inc | 26.23% | 2,762,688 | $1.16M | Institution |
| Robert J. Palmisano | 21.85% | 2,301,021 | $966.43k | Insider |
| Strathspey Crown Holdings Group LLC | 19.29% | 2,031,773 | $853.34k | Insider |
| Marc Forth | 7.13% | 750,547 | $315.23k | Insider |
| Vanguard Group Inc | 7.11% | 749,091 | $314.62k | Institution |
| Barclays PLC | 6.67% | 702,645 | $295.11k | Insider |
| Formidable Asset Management LLC | 6.54% | 689,182 | $289.46k | Institution |
AEON vs Biotech Stocks
Aeon Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.